Serum albumin as a marker for disease activity in patients with systemic lupus erythematosus

Journal of Rheumatology

Volumn 37, Issue 8, 2010, Pages 1667-1672

  Yip, Jonathan ^a   Aghdassi, Elaheh ^a   Su, Jiandong ^a   Lou, Wendy ^b   Reich, Heather ^c   Bargman, Joanne ^c   Scholey, James ^c   Gladman, Dafna D ^a,c   Urowitz, Murray B ^a,c   Fortin, Paul R ^a,c  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Albumin; Biomarker; Lupus nephritis; Systemic lupus erythematosus

Indexed keywords

DOUBLE STRANDED DNA; SERUM ALBUMIN;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE MARKER; FEMALE; FOLLOW UP; GOLD STANDARD; HISTOLOGY; HUMAN; KIDNEY BIOPSY; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; NEPHRITIS; PRIORITY JOURNAL; PROTEINURIA; RATING SCALE; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC LUPUS ERYTHEMATOSUS DISEASE ACTIVITY INDEX;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; DISABILITY EVALUATION; FEMALE; HEALTH STATUS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; REFERENCE VALUES; SERUM ALBUMIN; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 77955501234     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.091028     Document Type: Article

References (23)

1. Illei GG, Tackey E, Lapteva L, Lipsky PE. Biomarkers in systemic lupus erythematosus - II. Markers of disease activity. Arthritis Rheum 2004;50:2048-65.
2. Horak P, Scudla V, Hermanova Z, Pospisil Z, Faltynek L, Budikova M, et al. Clinical utility of selected disease activity markers in patients with systemic lupus erythematosus. Clin Rheumatol 2001;20:337-44. (Pubitemid 32936796)
3. Boehme MWJ, Raeth U, Galle PR, Stremmel W, Scherbaum WA. Serum thrombomodulin - a reliable marker of disease activity in systemic lupus erythematosus (SLE): advantage over established serological parameters to indicate disease activity. Clin Exp Immunol 2000;119:189-95. (Pubitemid 30064609)
4. Shojania K. Rheumatology: 2. What laboratory tests are needed? Can Med Assoc J 2000;162:1157-63.
5. Wallace DJ, Hahn BH. Serum and plasma protein abnormalities and other clinical laboratory determinations in systemic lupus erythematosus. In: Wallace DJ, Hahn BH, Quismorio FP Jr, Klinenberg JR, editors. Dubois' lupus erythematosus. Philadelphia: Lippincott Williams & Wilkins; 2006:911-9.
6. Sule SD, Fadrowski JJ, Fivush BA, Gorman G, Furth SL. Reduced albumin levels and utilization of arteriovenous access in pediatric patients with systemic lupus erythematosus (SLE). Pediatr Nephrol 2007;22:2041-6. (Pubitemid 350090710)
7. Huang ST, Chen GY, Wu CH, Kuo CD. Effect of disease activity and position on autonomic nervous modulation in patients with systemic lupus erythematosus. Clin Rheumatol 2008;27:295-300.
8. Don BR, Kaysen G. Serum albumin: relationship to inflammation and nutrition. Semin Dial 2004;17:432-7.
9. Suzuki M, Wiers K, Brooks EB, Greis KD, Haines K, Klein-Gitelman MS, et al. Initial validation of a novel protein biomarker panel for active pediatric lupus nephritis. Pediatr Res 2009;65:530-6.
10. Margarson MP, Soni N. Serum albumin: touchstone or totem? Anaesthesia 1998;53:789-803.
11. Dziedzic T, Slowik A, Szczudlik A. Serum albumin level as a predictor of ischemic stroke outcome. Stroke 2004;35:E156-8.
12. Corti MC, Guralnik JM, Salive ME, Sorkin JD. Serum-albumin level and physical disability as predictors of mortality in older persons. JAMA 1994;272:1036-42.
13. Gomi I, Fukushima H, Shiraki M, Miwa Y, Ando T, Takai K, et al. Relationship between serum albumin level and aging in community-dwelling self-supported elderly population. J Nutr Sci Vitaminol 2007;53:37-42. (Pubitemid 46623915)
14. Gibbs J, Cull W, Henderson W, Daley J, Hur K, Khuri SF. Preoperative serum albumin level as a predictor of operative mortality and morbidity: results from the National VA Surgical Risk Study. Arch Surg 1999;134:36-42. (Pubitemid 29047211)
15. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. Special Article - the 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
16. Gladman DD, Ibanez D, Urowitz MB. Systemic Lupus Erythematosus Disease Activity Index 2000. J Rheumatol 2002;29:288-91.
17. Abrahamowicz M, Fortin PR, du Berger R, Nayak V, Neville C, Liang MH. The relationship between disease activity and expert physician's decision to start major treatment in active systemic lupus erythematosus: A decision aid for development of entry criteria for clinical trials. J Rheumatol 1998;25:277-84. (Pubitemid 28088255)
18. Edwards LJ, Muller KE, Wolfinger RD, Qaqish BF, Schabenberger O. An R2 statistic for fixed effects in the linear mixed model. Stat Med 2008;27:6137-57.
19. Littell RC, Stroup WW, Freund RJ. SAS for linear models. 4th ed. Cary, NC: SAS Institute Inc.; 2002.
20. Straub RH, Zeuner M, Lock G, Rath H, Hein R, Scholmerich J, et al. Autonomic and sensorimotor neuropathy in patients with systemic lupus erythematosus and systemic sclerosis. J Rheumatol 1996;23:87-92. (Pubitemid 26036001)
21. Batlle-Gualda E, Martinez AC, Guerra RA, Pascual E. Urinary albumin excretion in patients with systemic lupus erythematosus without renal disease. Ann Rheum Dis 1997;56:386-9. (Pubitemid 27305429)
22. de Almeida RV, de Carvalho JGR, de Azevedo VF, Mulinari RA, Ioshhi SO, Utiyama SD, et al. Microalbuminuria and renal morphology in the evaluation of subclinical lupus nephritis. Clin Nephrol 1999;52:218-29.
23. Birmingham DJ, Rovin BH, Shidham G, Bissell M, Nagaraja HN, Hebert LA. Relationship between albuminuria and total proteinuria in systemic lupus erythematosus nephritis: Diagnostic and therapeutic implications. Clin J Am Soc Nephrol 2008;3:1028-33.